
PMC:7199903 / 666-789
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T6 | 94-102 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 22-23 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 103-108 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T4 | 62-69 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 70-77 | http://purl.obolibrary.org/obo/BFO_0000019 | denotes | quality |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T97 | 0-3 | DT | denotes | The |
T98 | 4-12 | NN | denotes | analysis |
T99 | 13-21 | VBZ | denotes | provides |
T100 | 22-23 | DT | denotes | a |
T101 | 24-33 | NN | denotes | benchmark |
T102 | 34-38 | WDT | denotes | that |
T103 | 39-42 | MD | denotes | can |
T104 | 43-45 | VB | denotes | be |
T105 | 46-50 | VBN | denotes | used |
T106 | 51-53 | TO | denotes | to |
T107 | 54-61 | VB | denotes | measure |
T108 | 62-69 | NN | denotes | antigen |
T109 | 70-77 | NN | denotes | quality |
T110 | 78-80 | IN | denotes | as |
T111 | 81-89 | NNS | denotes | vaccines |
T112 | 90-93 | CC | denotes | and |
T113 | 94-102 | NN | denotes | antibody |
T114 | 103-108 | NNS | denotes | tests |
T115 | 109-112 | VBP | denotes | are |
T116 | 113-122 | VBN | denotes | developed |
R100 | T98 | T97 | arg1Of | analysis,The |
R101 | T98 | T99 | arg1Of | analysis,provides |
R102 | T101 | T99 | arg2Of | benchmark,provides |
R103 | T101 | T100 | arg1Of | benchmark,a |
R104 | T101 | T102 | arg1Of | benchmark,that |
R105 | T101 | T103 | arg1Of | benchmark,can |
R106 | T105 | T103 | arg2Of | used,can |
R107 | T101 | T104 | arg1Of | benchmark,be |
R108 | T105 | T104 | arg2Of | used,be |
R109 | T101 | T105 | arg2Of | benchmark,used |
R110 | T107 | T105 | arg3Of | measure,used |
R111 | T107 | T106 | arg1Of | measure,to |
R112 | T101 | T107 | arg1Of | benchmark,measure |
R113 | T109 | T107 | arg2Of | quality,measure |
R114 | T109 | T108 | arg1Of | quality,antigen |
R115 | T107 | T110 | arg1Of | measure,as |
R116 | T116 | T110 | arg2Of | developed,as |
R117 | T111 | T112 | arg1Of | vaccines,and |
R118 | T114 | T112 | arg2Of | tests,and |
R119 | T114 | T113 | arg1Of | tests,antibody |
R120 | T112 | T115 | arg1Of | and,are |
R121 | T116 | T115 | arg2Of | developed,are |
R122 | T112 | T116 | arg2Of | and,developed |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T6 | 94-102 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-123 | Sentence | denotes | The analysis provides a benchmark that can be used to measure antigen quality as vaccines and antibody tests are developed. |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-123 | Sentence | denotes | The analysis provides a benchmark that can be used to measure antigen quality as vaccines and antibody tests are developed. |